David J. Hawellek

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia.

A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia.

Journal: Frontiers in digital health

Published: March 27, 2026

Quantitative relationship between tominersen concentrations in cerebrospinal fluid and biomarker changes in Huntington's disease patients.

Quantitative relationship between tominersen concentrations in cerebrospinal fluid and biomarker changes in Huntington's disease patients.

Journal: British journal of clinical pharmacology

Published: June 10, 2025

Clinically altered brain activity may not look like aged brain activity: Implications for brain-age modeling and biomarker strategies.

Clinically altered brain activity may not look like aged brain activity: Implications for brain-age modeling and biomarker strategies.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: May 09, 2025

Benchmarking the utility of dry-electrode electroencephalography for clinical trials.

Benchmarking the utility of dry-electrode electroencephalography for clinical trials.

Journal: Scientific reports

Published: November 06, 2024

Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease mice.

Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease mice.

Journal: Translational neurodegeneration

Published: May 06, 2024

Tominersen in Adults with Manifest Huntington's Disease.

Tominersen in Adults with Manifest Huntington's Disease.

Journal: The New England journal of medicine

Published: December 06, 2023

Neural representations of the content and production of human vocalization.

Neural representations of the content and production of human vocalization.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 30, 2023

Quantifying mutant huntingtin protein in human cerebrospinal fluid to support the development of huntingtin-lowering therapies.

Quantifying mutant huntingtin protein in human cerebrospinal fluid to support the development of huntingtin-lowering therapies.

Journal: Scientific reports

Published: November 29, 2022

Changes in brain activity with tominersen in early-manifest Huntington's disease.

Changes in brain activity with tominersen in early-manifest Huntington's disease.

Journal: Brain communications

Published: November 22, 2021

Motion Coherence and Luminance Contrast Interact in Driving Visual Gamma-Band Activity.

Motion Coherence and Luminance Contrast Interact in Driving Visual Gamma-Band Activity.

Journal: Cerebral cortex (New York, N.Y. : 1991)

Published: August 20, 2019

Altered intrinsic neuronal interactions in the visual cortex of the blind.

Altered intrinsic neuronal interactions in the visual cortex of the blind.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: October 25, 2013

Impairment of GABA transporter GAT-1 terminates cortical recurrent network activity via enhanced phasic inhibition.

Impairment of GABA transporter GAT-1 terminates cortical recurrent network activity via enhanced phasic inhibition.

Journal: Frontiers in neural circuits

Published: April 25, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026